Skip to main content
Erschienen in: Brain Tumor Pathology 2/2019

09.04.2019 | Review Article

Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features

verfasst von: Takuichiro Hide, Ichiyo Shibahara, Toshihiro Kumabe

Erschienen in: Brain Tumor Pathology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Glioblastoma (GBM) is a major malignant brain tumor developing in adult brain white matter, characterized by rapid growth and invasion. GBM cells spread into the contralateral hemisphere, even during early tumor development. However, after complete resection of tumor mass, GBM commonly recurs around the tumor removal cavity, suggesting that a microenvironment at the tumor border provides chemo-radioresistance to GBM cells. Thus, clarification of the tumor border microenvironment is critical for improving prognosis in GBM patients. MicroRNA (miRNA) expression in samples from the tumor, tumor border, and peripheral region far from tumor mass was compared, and five miRNAs showing characteristically higher expression in the tumor border were identified, with the top three related to oligodendrocyte differentiation. Pathologically, oligodendrocyte lineage cells increased in the border, but were rare in tumors. Macrophages/microglia also colocalized in the border area. Medium cultured with oligodendrocyte progenitor cells (OPCs) and macrophages induced stemness and chemo-radioresistance in GBM cells, suggesting that OPCs and macrophages/microglia constitute a special microenvironment for GBM cells at the tumor border. The supportive function of OPCs for GBM cells has not been discussed previously. OPCs are indispensable for GBM cells to establish special niches for chemo-radioresistance outside the tumor mass.
Literatur
1.
Zurück zum Zitat Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466CrossRefPubMed Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466CrossRefPubMed
2.
Zurück zum Zitat Ostrom QT, Gittleman H, Liao P et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16(Suppl 4):iv1-63CrossRefPubMed Ostrom QT, Gittleman H, Liao P et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16(Suppl 4):iv1-63CrossRefPubMed
3.
Zurück zum Zitat Wilson CB (1992) Glioblastoma: the past, the present, and the future. Clin Neurosurg 38:32–48PubMed Wilson CB (1992) Glioblastoma: the past, the present, and the future. Clin Neurosurg 38:32–48PubMed
4.
Zurück zum Zitat Brandes AA, Tosoni A, Franceschi E et al (2009) Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status. J Clin Oncol 27:1275–1279CrossRefPubMed Brandes AA, Tosoni A, Franceschi E et al (2009) Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status. J Clin Oncol 27:1275–1279CrossRefPubMed
5.
Zurück zum Zitat Schaub C, Kebir S, Junold N et al (2018) Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. J Cancer Res Clin Oncol 144:1581–1589CrossRefPubMed Schaub C, Kebir S, Junold N et al (2018) Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial. J Cancer Res Clin Oncol 144:1581–1589CrossRefPubMed
6.
Zurück zum Zitat Hide T, Komohara Y, Miyasato Y et al (2018) Oligodendrocyte progenitor cells and macrophages/microglia produce glioma stem cell niches at the tumor border. EBioMedicine 30:94–104CrossRefPubMedPubMedCentral Hide T, Komohara Y, Miyasato Y et al (2018) Oligodendrocyte progenitor cells and macrophages/microglia produce glioma stem cell niches at the tumor border. EBioMedicine 30:94–104CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401CrossRefPubMed Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401CrossRefPubMed
8.
Zurück zum Zitat Hide T, Makino K, Nakamura H et al (2013) New treatment strategies to eradicate cancer stem cells and niches in glioblastoma. Neurol Med Chir (Tokyo) 53:764–772CrossRef Hide T, Makino K, Nakamura H et al (2013) New treatment strategies to eradicate cancer stem cells and niches in glioblastoma. Neurol Med Chir (Tokyo) 53:764–772CrossRef
9.
Zurück zum Zitat Charles NA, Holland EC, Gilbertson R et al (2011) The brain tumor microenvironment. Glia 59:1169–1180CrossRefPubMed Charles NA, Holland EC, Gilbertson R et al (2011) The brain tumor microenvironment. Glia 59:1169–1180CrossRefPubMed
10.
Zurück zum Zitat Fidoamore A, Cristiano L, Antonosante A et al (2016) Glioblastoma stem cells microenvironment: the paracrine roles of the niche in drug and radioresistance. Stem Cells Int 2016:6809105CrossRefPubMedPubMedCentral Fidoamore A, Cristiano L, Antonosante A et al (2016) Glioblastoma stem cells microenvironment: the paracrine roles of the niche in drug and radioresistance. Stem Cells Int 2016:6809105CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Ishii A, Kimura T, Sadahiro H et al (2016) Histological characterization of the tumorigenic “Peri-Necrotic Niche” harboring quiescent stem-like tumor cells in glioblastoma. PLoS One 11:e0147366CrossRefPubMedPubMedCentral Ishii A, Kimura T, Sadahiro H et al (2016) Histological characterization of the tumorigenic “Peri-Necrotic Niche” harboring quiescent stem-like tumor cells in glioblastoma. PLoS One 11:e0147366CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Schiffer D, Annovazzi L, Casalone C et al (2018) Glioblastoma: microenvironment and niche concept. Cancers (Basel) 11(1):5CrossRef Schiffer D, Annovazzi L, Casalone C et al (2018) Glioblastoma: microenvironment and niche concept. Cancers (Basel) 11(1):5CrossRef
14.
Zurück zum Zitat Schiffer D, Mellai M, Bovio E et al (2018) Glioblastoma niches: from the concept to the phenotypical reality. Neurol Sci 39:1161–1168CrossRefPubMed Schiffer D, Mellai M, Bovio E et al (2018) Glioblastoma niches: from the concept to the phenotypical reality. Neurol Sci 39:1161–1168CrossRefPubMed
15.
Zurück zum Zitat Lathia JD, Heddleston JM, Venere M et al (2011) Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell 8:482–485CrossRefPubMedPubMedCentral Lathia JD, Heddleston JM, Venere M et al (2011) Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell 8:482–485CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Leblond MM, Peres EA, Helaine C et al (2017) M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma. Oncotarget 8:72597–72612CrossRefPubMedPubMedCentral Leblond MM, Peres EA, Helaine C et al (2017) M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma. Oncotarget 8:72597–72612CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Arcuri C, Fioretti B, Bianchi R et al (2017) Microglia-glioma cross-talk: a two way approach to new strategies against glioma. Front Biosci (Landmark Ed) 22:268–309CrossRef Arcuri C, Fioretti B, Bianchi R et al (2017) Microglia-glioma cross-talk: a two way approach to new strategies against glioma. Front Biosci (Landmark Ed) 22:268–309CrossRef
19.
Zurück zum Zitat Roesch S, Rapp C, Dettling S et al (2018) When immune cells turn bad-tumor-associated microglia/macrophages in glioma. Int J Mol Sci 19:436CrossRefPubMedCentral Roesch S, Rapp C, Dettling S et al (2018) When immune cells turn bad-tumor-associated microglia/macrophages in glioma. Int J Mol Sci 19:436CrossRefPubMedCentral
20.
Zurück zum Zitat Kros JM, Mustafa DM, Dekker LJ et al (2015) Circulating glioma biomarkers. Neuro Oncol 17:343–360CrossRefPubMed Kros JM, Mustafa DM, Dekker LJ et al (2015) Circulating glioma biomarkers. Neuro Oncol 17:343–360CrossRefPubMed
21.
Zurück zum Zitat Li C, Sun J, Xiang Q et al (2016) Prognostic role of microRNA-21 expression in gliomas: a meta-analysis. J Neurooncol 130:11–17CrossRefPubMed Li C, Sun J, Xiang Q et al (2016) Prognostic role of microRNA-21 expression in gliomas: a meta-analysis. J Neurooncol 130:11–17CrossRefPubMed
22.
Zurück zum Zitat Kohlhapp FJ, Mitra AK, Lengyel E et al (2015) MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene 34:5857CrossRefPubMedPubMedCentral Kohlhapp FJ, Mitra AK, Lengyel E et al (2015) MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene 34:5857CrossRefPubMedPubMedCentral
23.
25.
Zurück zum Zitat Dugas JC, Cuellar TL, Scholze A et al (2010) Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 65:597–611CrossRefPubMedPubMedCentral Dugas JC, Cuellar TL, Scholze A et al (2010) Dicer1 and miR-219 Are required for normal oligodendrocyte differentiation and myelination. Neuron 65:597–611CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Nazari B, Soleimani M, Ebrahimi-Barough S et al (2018) Overexpression of miR-219 promotes differentiation of human induced pluripotent stem cells into pre-oligodendrocyte. J Chem Neuroanat 91:8–16CrossRefPubMed Nazari B, Soleimani M, Ebrahimi-Barough S et al (2018) Overexpression of miR-219 promotes differentiation of human induced pluripotent stem cells into pre-oligodendrocyte. J Chem Neuroanat 91:8–16CrossRefPubMed
28.
Zurück zum Zitat Wegener A, Deboux C, Bachelin C et al (2015) Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination. Brain 138:120–135CrossRefPubMed Wegener A, Deboux C, Bachelin C et al (2015) Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination. Brain 138:120–135CrossRefPubMed
29.
Zurück zum Zitat Birey F, Kokkosis AG, Aguirre A (2017) Oligodendroglia-lineage cells in brain plasticity, homeostasis and psychiatric disorders. Curr Opin Neurobiol 47:93–103CrossRefPubMedPubMedCentral Birey F, Kokkosis AG, Aguirre A (2017) Oligodendroglia-lineage cells in brain plasticity, homeostasis and psychiatric disorders. Curr Opin Neurobiol 47:93–103CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Lou W, Zhang X, Hu XY et al (2016) MicroRNA-219-5p inhibits morphine-induced apoptosis by targeting key cell cycle regulator WEE1. Med Sci Monit 22:1872–1879CrossRefPubMedPubMedCentral Lou W, Zhang X, Hu XY et al (2016) MicroRNA-219-5p inhibits morphine-induced apoptosis by targeting key cell cycle regulator WEE1. Med Sci Monit 22:1872–1879CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Kuratsu J, Leonard EJ, Yoshimura T (1989) Production and characterization of human glioma cell-derived monocyte chemotactic factor. J Natl Cancer Inst 81:347–351CrossRefPubMed Kuratsu J, Leonard EJ, Yoshimura T (1989) Production and characterization of human glioma cell-derived monocyte chemotactic factor. J Natl Cancer Inst 81:347–351CrossRefPubMed
32.
Zurück zum Zitat Komohara Y, Horlad H, Ohnishi K et al (2012) Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer Sci 103:2165–2172CrossRefPubMedPubMedCentral Komohara Y, Horlad H, Ohnishi K et al (2012) Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer Sci 103:2165–2172CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Hambardzumyan D, Gutmann DH, Kettenmann H (2016) The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci 19:20–27CrossRefPubMedPubMedCentral Hambardzumyan D, Gutmann DH, Kettenmann H (2016) The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci 19:20–27CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Pyonteck SM, Akkari L, Schuhmacher AJ et al (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19:1264–1272CrossRefPubMedPubMedCentral Pyonteck SM, Akkari L, Schuhmacher AJ et al (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19:1264–1272CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Komohara Y, Jinushi M, Takeya M (2014) Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 105:1–8CrossRefPubMed Komohara Y, Jinushi M, Takeya M (2014) Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 105:1–8CrossRefPubMed
37.
Zurück zum Zitat Jahani-Asl A, Yin H, Soleimani VD et al (2016) Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat Neurosci 19:798–806CrossRefPubMedPubMedCentral Jahani-Asl A, Yin H, Soleimani VD et al (2016) Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat Neurosci 19:798–806CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Kaneko S, Nakatani Y, Takezaki T et al (2015) Ceacam1L modulates STAT3 signaling to control the proliferation of glioblastoma-initiating cells. Cancer Res 75:4224–4234CrossRefPubMed Kaneko S, Nakatani Y, Takezaki T et al (2015) Ceacam1L modulates STAT3 signaling to control the proliferation of glioblastoma-initiating cells. Cancer Res 75:4224–4234CrossRefPubMed
39.
Zurück zum Zitat Diksin M, Smith SJ, Rahman R (2017) The molecular and phenotypic basis of the glioma invasive perivascular niche. Int J Mol Sci 18(11):2342CrossRefPubMedCentral Diksin M, Smith SJ, Rahman R (2017) The molecular and phenotypic basis of the glioma invasive perivascular niche. Int J Mol Sci 18(11):2342CrossRefPubMedCentral
40.
Zurück zum Zitat Calabrese C, Poppleton H, Kocak M et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69–82CrossRefPubMed Calabrese C, Poppleton H, Kocak M et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11:69–82CrossRefPubMed
41.
Zurück zum Zitat Ho IAW, Shim WSN (2017) Contribution of the microenvironmental Niche to glioblastoma heterogeneity. Biomed Res Int 2017:9634172PubMedPubMedCentral Ho IAW, Shim WSN (2017) Contribution of the microenvironmental Niche to glioblastoma heterogeneity. Biomed Res Int 2017:9634172PubMedPubMedCentral
44.
Zurück zum Zitat Yeung MS, Zdunek S, Bergmann O et al (2014) Dynamics of oligodendrocyte generation and myelination in the human brain. Cell 159:766–774CrossRefPubMed Yeung MS, Zdunek S, Bergmann O et al (2014) Dynamics of oligodendrocyte generation and myelination in the human brain. Cell 159:766–774CrossRefPubMed
45.
46.
Zurück zum Zitat Hide T, Takezaki T, Nakatani Y et al (2011) Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells. Stem Cells 29:590–599CrossRefPubMed Hide T, Takezaki T, Nakatani Y et al (2011) Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells. Stem Cells 29:590–599CrossRefPubMed
47.
48.
Zurück zum Zitat Galvao RP, Kasina A, McNeill RS et al (2014) Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process. Proc Natl Acad Sci USA 111:E4214–E4223CrossRefPubMedPubMedCentral Galvao RP, Kasina A, McNeill RS et al (2014) Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process. Proc Natl Acad Sci USA 111:E4214–E4223CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Hughes EG, Kang SH, Fukaya M et al (2013) Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat Neurosci 16:668–676CrossRefPubMedPubMedCentral Hughes EG, Kang SH, Fukaya M et al (2013) Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat Neurosci 16:668–676CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Fernandez-Castaneda A, Gaultier A (2016) Adult oligodendrocyte progenitor cells—multifaceted regulators of the CNS in health and disease. Brain Behav Immun 57:1–7CrossRefPubMedPubMedCentral Fernandez-Castaneda A, Gaultier A (2016) Adult oligodendrocyte progenitor cells—multifaceted regulators of the CNS in health and disease. Brain Behav Immun 57:1–7CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Young KM, Psachoulia K, Tripathi RB et al (2013) Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 77:873–885CrossRefPubMedPubMedCentral Young KM, Psachoulia K, Tripathi RB et al (2013) Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron 77:873–885CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Marques S, Zeisel A, Codeluppi S et al (2016) Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science 352:1326–1329CrossRefPubMedPubMedCentral Marques S, Zeisel A, Codeluppi S et al (2016) Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science 352:1326–1329CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Hosono J, Morikawa S, Ezaki T et al (2017) Pericytes promote abnormal tumor angiogenesis in a rat RG2 glioma model. Brain Tumor Pathol 34:120–129CrossRefPubMed Hosono J, Morikawa S, Ezaki T et al (2017) Pericytes promote abnormal tumor angiogenesis in a rat RG2 glioma model. Brain Tumor Pathol 34:120–129CrossRefPubMed
56.
Zurück zum Zitat Butovsky O, Ziv Y, Schwartz A et al (2006) Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 31:149–160CrossRefPubMed Butovsky O, Ziv Y, Schwartz A et al (2006) Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci 31:149–160CrossRefPubMed
57.
Zurück zum Zitat Shigemoto-Mogami Y, Hoshikawa K, Goldman JE et al (2014) Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone. J Neurosci 34:2231–2243CrossRefPubMedPubMedCentral Shigemoto-Mogami Y, Hoshikawa K, Goldman JE et al (2014) Microglia enhance neurogenesis and oligodendrogenesis in the early postnatal subventricular zone. J Neurosci 34:2231–2243CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Miron VE (2017) Microglia-driven regulation of oligodendrocyte lineage cells, myelination, and remyelination. J Leukoc Biol 101:1103–1108CrossRefPubMed Miron VE (2017) Microglia-driven regulation of oligodendrocyte lineage cells, myelination, and remyelination. J Leukoc Biol 101:1103–1108CrossRefPubMed
59.
Zurück zum Zitat Chen Z, Feng X, Herting CJ et al (2017) Cellular and molecular identity of tumor-associated macrophages in glioblastoma. Cancer Res 77:2266–2278CrossRefPubMedPubMedCentral Chen Z, Feng X, Herting CJ et al (2017) Cellular and molecular identity of tumor-associated macrophages in glioblastoma. Cancer Res 77:2266–2278CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Guan X, Hasan MN, Maniar S et al (2018) Reactive astrocytes in glioblastoma multiforme. Mol Neurobiol 55:6927–6938CrossRefPubMed Guan X, Hasan MN, Maniar S et al (2018) Reactive astrocytes in glioblastoma multiforme. Mol Neurobiol 55:6927–6938CrossRefPubMed
62.
Zurück zum Zitat Brandao M, Simon T, Critchley G et al (2019) Astrocytes, the rising stars of the glioblastoma microenvironment. Glia 67:779–790CrossRefPubMed Brandao M, Simon T, Critchley G et al (2019) Astrocytes, the rising stars of the glioblastoma microenvironment. Glia 67:779–790CrossRefPubMed
63.
Zurück zum Zitat Katz AM, Amankulor NM, Pitter K et al (2012) Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment. PLoS One 7:e32453CrossRefPubMedPubMedCentral Katz AM, Amankulor NM, Pitter K et al (2012) Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment. PLoS One 7:e32453CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Barcia C Jr, Gomez A, Gallego-Sanchez JM et al (2009) Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cells. Am J Pathol 175:786–798CrossRefPubMedPubMedCentral Barcia C Jr, Gomez A, Gallego-Sanchez JM et al (2009) Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cells. Am J Pathol 175:786–798CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Lundgaard I, Osorio MJ, Kress BT et al (2014) White matter astrocytes in health and disease. Neuroscience 276:161–173CrossRefPubMed Lundgaard I, Osorio MJ, Kress BT et al (2014) White matter astrocytes in health and disease. Neuroscience 276:161–173CrossRefPubMed
66.
Zurück zum Zitat Moore CS, Abdullah SL, Brown A et al (2011) How factors secreted from astrocytes impact myelin repair. J Neurosci Res 89:13–21CrossRefPubMed Moore CS, Abdullah SL, Brown A et al (2011) How factors secreted from astrocytes impact myelin repair. J Neurosci Res 89:13–21CrossRefPubMed
67.
Zurück zum Zitat Bardehle S, Kruger M, Buggenthin F et al (2013) Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat Neurosci 16:580–586CrossRefPubMed Bardehle S, Kruger M, Buggenthin F et al (2013) Live imaging of astrocyte responses to acute injury reveals selective juxtavascular proliferation. Nat Neurosci 16:580–586CrossRefPubMed
68.
Zurück zum Zitat Gibson EM, Purger D, Mount CW et al (2014) Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344:1252304CrossRefPubMedPubMedCentral Gibson EM, Purger D, Mount CW et al (2014) Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344:1252304CrossRefPubMedPubMedCentral
69.
Zurück zum Zitat Mitew S, Gobius I, Fenlon LR et al (2018) Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner. Nat Commun 9:306CrossRefPubMedPubMedCentral Mitew S, Gobius I, Fenlon LR et al (2018) Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner. Nat Commun 9:306CrossRefPubMedPubMedCentral
70.
71.
Zurück zum Zitat Venkatesh HS, Tam LT, Woo PJ et al (2017) Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature 549:533–537CrossRefPubMedPubMedCentral Venkatesh HS, Tam LT, Woo PJ et al (2017) Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma. Nature 549:533–537CrossRefPubMedPubMedCentral
73.
74.
Zurück zum Zitat Muller C, Holtschmidt J, Auer M et al (2014) Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 6:247ra101CrossRefPubMed Muller C, Holtschmidt J, Auer M et al (2014) Hematogenous dissemination of glioblastoma multiforme. Sci Transl Med 6:247ra101CrossRefPubMed
75.
Zurück zum Zitat Macarthur KM, Kao GD, Chandrasekaran S et al (2014) Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. Cancer Res 74:2152–2159CrossRefPubMedPubMedCentral Macarthur KM, Kao GD, Chandrasekaran S et al (2014) Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay. Cancer Res 74:2152–2159CrossRefPubMedPubMedCentral
76.
Zurück zum Zitat Liu T, Xu H, Huang M et al (2018) Circulating glioma cells exhibit stem cell-like properties. Cancer Res 78:6632–6642PubMedPubMedCentral Liu T, Xu H, Huang M et al (2018) Circulating glioma cells exhibit stem cell-like properties. Cancer Res 78:6632–6642PubMedPubMedCentral
77.
Zurück zum Zitat Muragaki Y, Akimoto J, Maruyama T et al (2013) Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. J Neurosurg 119:845–852CrossRefPubMed Muragaki Y, Akimoto J, Maruyama T et al (2013) Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. J Neurosurg 119:845–852CrossRefPubMed
78.
Zurück zum Zitat Nitta M, Muragaki Y, Maruyama T et al (2018) Role of photodynamic therapy using talaporfin sodium and a semiconductor laser in patients with newly diagnosed glioblastoma. J Neurosurg 1:1–8CrossRef Nitta M, Muragaki Y, Maruyama T et al (2018) Role of photodynamic therapy using talaporfin sodium and a semiconductor laser in patients with newly diagnosed glioblastoma. J Neurosurg 1:1–8CrossRef
79.
Zurück zum Zitat Westphal M, Hilt DC, Bortey E et al (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79–88CrossRefPubMedPubMedCentral Westphal M, Hilt DC, Bortey E et al (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5:79–88CrossRefPubMedPubMedCentral
80.
Zurück zum Zitat Shibahara I, Hanihara M, Watanabe T et al (2018) Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system. J Neurooncol 137:417–427CrossRefPubMed Shibahara I, Hanihara M, Watanabe T et al (2018) Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system. J Neurooncol 137:417–427CrossRefPubMed
81.
Zurück zum Zitat Asano K, Kurose A, Kamataki A et al (2018) Importance and accuracy of intraoperative frozen section diagnosis of the resection margin for effective carmustine wafer implantation. Brain Tumor Pathol 35:131–140CrossRefPubMed Asano K, Kurose A, Kamataki A et al (2018) Importance and accuracy of intraoperative frozen section diagnosis of the resection margin for effective carmustine wafer implantation. Brain Tumor Pathol 35:131–140CrossRefPubMed
82.
Zurück zum Zitat Iuchi T, Hatano K, Kodama T et al (2014) Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 88:793–800CrossRefPubMed Iuchi T, Hatano K, Kodama T et al (2014) Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 88:793–800CrossRefPubMed
83.
Zurück zum Zitat Zschaeck S, Wust P, Graf R et al (2018) Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma. Radiat Oncol 13:251CrossRefPubMedPubMedCentral Zschaeck S, Wust P, Graf R et al (2018) Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma. Radiat Oncol 13:251CrossRefPubMedPubMedCentral
Metadaten
Titel
Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features
verfasst von
Takuichiro Hide
Ichiyo Shibahara
Toshihiro Kumabe
Publikationsdatum
09.04.2019
Verlag
Springer Singapore
Erschienen in
Brain Tumor Pathology / Ausgabe 2/2019
Print ISSN: 1433-7398
Elektronische ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-019-00341-2

Weitere Artikel der Ausgabe 2/2019

Brain Tumor Pathology 2/2019 Zur Ausgabe

Acknowledgment

Reviewers in 2018

Preface

Preface

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Vierten reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.